Back to TVTX
Kynam Capital Management, LP → TVTX
Kynam Capital Management, LP TVTX Position History
Travere Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$117.8M
Q3 2026
Peak value
$117.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $19.8M |
| Q1 2026 | $46.6M |
| Q1 2026 | $23.8M |
| Q1 2026 | $1.6M |
| Q2 2026 | $113.6M |
| Q3 2026 | $117.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $117.8M | 2.00M | — | — |
| Q2 2026 | $113.6M | 2.00M | — | — |
| Q1 2026 | $1.6M | 54.9K | — | — |
| Q1 2026 | $23.8M | 800.0K | — | — |
| Q1 2026 | $46.6M | 1.57M | — | — |
| Q4 2025 | $19.8M | 517.9K | — | — |
Other funds holding TVTX
$683.9M
$392.3M
$331.1M
$331.1M
$286.7M
$258.3M
$247M